Article Information
vol. 10 no. 432
- Received for publication June 16, 2017
- Accepted for publication February 14, 2018
- .
Author Information
- Stefan Roth1,2,
- Vikramjeet Singh1,2,
- Steffen Tiedt1,2,
- Lisa Schindler1,2,
- Georg Huber3,
- Arie Geerlof3,
- Daniel J. Antoine4,
- Antoine Anfray5,
- Cyrille Orset5,
- Maxime Gauberti5,
- Antoine Fournier5,
- Lesca M. Holdt6,
- Helena Erlandsson Harris7,
- Britta Engelhardt8,
- Marco E. Bianchi9,
- Denis Vivien5,
- Christof Haffner1,
- Jürgen Bernhagen1,2,
- Martin Dichgans1,2 and
- Arthur Liesz1,2,*
- 1Institute for Stroke and Dementia Research, Klinikum der Universität München, 81377 Munich, Germany.
- 2Munich Cluster for System Neurology (SyNergy), 80336 Munich, Germany.
- 3Institute of Structural Biology, Helmholtz Centre Munich, 85764 Munich, Germany.
- 4Medical Research Council Center for Drug Safety Science, Department for Molecular and Clinical Pharmacology, University of Liverpool, L69 3GE Liverpool, UK.
- 5INSERM, Université de Caen-Normandie, CHU de Caen, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders, GIP Cyceron, 14074 Caen, France.
- 6Institute of Laboratory Medicine, Klinikum der Universität München, 81377 Munich, Germany.
- 7Department of Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
- 8Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012 Bern, Switzerland.
- 9Faculty of Medicine, San Raffaele University, 20132, Milan, Italy.
- ↵*Corresponding author. Email: arthur.liesz{at}med.uni-muenchen.de